|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/70 | |
| A61K 39/09 |
| (11) | Patento numeris | 2917351 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13788753.5 |
| Europos patento paraiškos padavimo data | 2013-11-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/073266 |
| Data | 2013-11-07 |
| (87) | Numeris | WO 2014/072405 |
| Data | 2014-05-15 |
| (30) | Numeris | Data | Šalis |
| 201261723408 P | 2012-11-07 | US |
| (72) |
WACKER, Michael, CH
KOWARIK, Michael, CH
WETTER, Michael, CH
FARIDMOAYER, Amirreza, CH
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |
| PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |